Dria Ventures

Dria Ventures is an early-stage venture capital firm that provides strategic seed investments to companies addressing high-cost and underserved sectors across the United States. The firm focuses on two critical areas: healthcare and Main Street productivity. In healthcare, Dria Ventures targets clinically-driven tech companies improving access to therapists and medications for mental disorders, and software expanding access to fertility care. For Main Street productivity, they invest in solutions that bring modern software and automation to historically overlooked industries such as auto repair, logistics, and food service.

Dria Ventures was founded in 2024 by Megan Maloney, who serves as the Founder and Managing Partner. The firm's name, "Dria," is an homage to Maloney's grandmothers, Dorothy and Sylvia, both independent and strong women. Maloney's investment thesis is deeply rooted in her lived experiences, including her mother's medical practice being impacted by fraud and witnessing the positive impact of technology like Livongo on her grandmother's health. This background shaped her understanding of systemic costs and the potential for technology to drive breakthroughs.

Dria Ventures makes pre-seed and seed investments, typically entering post-first customer but pre-product market fit. The firm has made several investments in companies like Karoo Health, Terial, Vibrant, Kintow, and PitPro Automation. Other notable investments include Longwave, EXPIN, Olira, Quotient, and Juniper Genomics, spanning industries such as Internet Software, Healthcare Technology Systems, Business/Productivity Software, and Biotechnology.

Megan Maloney, the founder and managing partner, brings over ten years of experience investing in both early-stage and growth-stage companies, including her time at General Catalyst where she served as a board observer for companies like Livongo, Samsara, and Grammarly, and invested in Stripe. Dria Ventures differentiates itself through hands-on, operator-level support, offering day-to-day guidance, operating model deep dives, and 1x1 advice from top operators. The firm also provides portfolio companies with deep access to multi-stage investors and mid-size customers. Richard Goldstein, a venture partner, has been instrumental in developing the firm's healthcare thesis.